Acelity Expands Wound Care Portfolio with Introduction of Advanced Foam Dressing Line in the U.S.

Released : 13 Abril 2016

Seven new products now available from the TIELLE™ Foam Dressing Family complement extensive therapeutic options for chronic and acute wounds

SAN ANTONIO, April 13, 2016 – Acelity™, a global advanced wound care and regenerative medicine company, announced today that its TIELLE™ Foam Dressing Family is now available in the United States. The TIELLETM Dressing Family expands the industry-leading advanced wound therapeutics portfolio from Acelity. This expansion complements a broad range of existing solutions for chronic and acute wounds and provides clinicians with efficient and cost-effective options for treating patients. The Company announced the availability of these products at the joint meeting of the Symposium of Advanced Wound Care and the Wound Healing Society (SAWC Spring/WHS) in Atlanta.  

 

“Our goal was to reinvigorate the range of proven TIELLE™ Dressings and introduce it to clinicians here in the U.S. who are seeking effective solutions for all patients, including the most compromised,” said Joe Woody, president and chief executive officer of Acelity. “We aim to strengthen our partnership with nurses and physicians by broadening our platform to include an extensive range of dressings, advancements in negative pressure technology and new innovations designed to help speed healing for patients and reduce the overall cost of care.”  

 

The TIELLETM Foam Dressing Family was designed to meet the needs of healthcare professionals, including exudate management and reduced pain for the patient at dressing removal.

 

The TIELLETM Hydropolymer Dressings – TIELLE™ Silicone Border and TIELLE™ Non-Adhesive – include the unique LIQUALOCKTM Advanced Absorption Technology which locks fluid away to help prevent leakage and maceration. Both dressings are intended to manage a range of exudate levels in partial or full thickness wounds. They are designed to help maintain a moist wound healing environment through the combination of fluid absorption and moisture vapor transfer rate (MVTR), and to be worn for up to seven days depending on the wound condition and exudate levels, which may help reduce the number of dressing changes and associated cost, a benefit for patients, payors and providers.

·         TIELLE™ Silicone Border is intended to manage a range of exudate levels in partial or full thickness wounds. The soft silicone adhesive spans the full extent of the dressing, allowing for gentle removal, helping to minimize pain and trauma for the patient.

·         TIELLE™ Non-Adhesive is a low profile dressing, which supports patient comfort and may be cut to size.

 

TIELLE ESSENTIAL™ Foam Dressings provide a range of economical foam dressings designed to absorb moderate to heavy exudate, maintaining a moist healing environment to aid in the healing process for chronic and acute wounds.The range of new available dressings includes:

·         TIELLE ESSENTIAL™ Non-Adhesive and Heel

·         TIELLE ESSENTIAL™ Border

·         TIELLE ESSENTIAL™ Silicone Border

·         TIELLE ESSENTIAL™ Silicone Border Sacrum

·         TIELLE ESSENTIAL™ Silicone

 

“Acelity will continue to strengthen our portfolio of wound care and regenerative medicine products to provide clinicians the most options at every step of the care continuum – from the O.R., to the hospital room and at home,” said Woody.

 

Systagenix, an Acelity company, introduced the TIELLE™ Hydropolymer Dressing range in Europe in 1992. In 2013, KCI commercialized Negative Pressure Wound Therapy with the introduction of the V.A.C.® Therapy System in 1995 and then strengthened its position in the global wound therapeutics industry by acquiring Systagenix in 2012, increasing the company’s ability to offer best-in-class products across the wound care continuum. In 2014, KCI, Systagenix, and LifeCell, a developer of tissue repair products, combined to form Acelity, a global corporation devoted to the art and science of healing.

 

About Acelity

Acelity L.P. Inc. and its subsidiaries are a global advanced wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. Available in more than 80 countries, the innovative and complementary Acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,800 people around the world.

 

For more information, contact:
 
Kathryn Skeen
Corporate Communications
Phone: +1-210-882-2067
Email: kathryn.skeen@acelity.com
 
Caleb Moore
Investor Relations
Phone: +1-210-255-6433
Email: caleb.moore@acelity.com

Mensagem Importante para os Pacientes

Termos de Uso | Política de Privacidade do Site da KCI | Entre em contato conosco


Copyright © 1998 – 2013 KCI Licensing, Inc Todos os Direitos Reservados.    DSL#12-0512.BR
As informações incluídas neste site foram preparadas para e com o intuito de serem visualizadas exclusivamente por profissionais da saúde no Brasil. Este site contém informações sobre produtos que podem ou não estar disponíveis em países diferentes e, se aplicável, podem ou não ter recebido aprovação ou liberação comercial por uma agência regulatória governamental para indicações diferentes e restrições em diferentes países.